Daily Archives: June 6, 2022

Analysis of Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Disorders of Gut-Brain Interaction

Posted in News | Comments Off on Analysis of Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Disorders of Gut-Brain Interaction

Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease

Seeberg KA, Borgeraas H, Hofsø H, et al. Gastric bypass versus sleeve gastrectomy in type 2 diabetes: effects on hepatic steatosis and fibrosis: a randomized controlled trial. Ann Intern Med 2022;175:74–83. Continue reading

Posted in News | Comments Off on Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease

Metabolome changes with diet-induced remission in pediatric Crohn’s disease

Crohn’s Disease Exclusion Diet + Partial Enteral Nutrition (CDED+PEN) and exclusive enteral nutrition (EEN) both induce remission in pediatric Crohn’s disease (CD). CDED+PEN is better tolerated and able to sustain remission. We characterized the change… Continue reading

Posted in News | Comments Off on Metabolome changes with diet-induced remission in pediatric Crohn’s disease

Uncovering 1,058 novel human enteric DNA viruses through deep long-read third-generation sequencing and their clinical impact

Lack of viral reference genomes poses a challenge to virome study. We investigated human gut virome and its clinical implication by ultra-deep metagenomic sequencing. Continue reading

Posted in News | Comments Off on Uncovering 1,058 novel human enteric DNA viruses through deep long-read third-generation sequencing and their clinical impact

Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the US and Europe: Randomized Clinical Trial

Novel, effective treatments for Helicobacter pylori infection are needed. This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, versus standard treatment on H. pylori eradication in the US and Europe. Continue reading

Posted in News | Comments Off on Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the US and Europe: Randomized Clinical Trial

A MULTICENTER RANDOMIZED CONTROLLED TRIAL OF SURVEILLANCE VERSUS ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: THE SURVENT TRIAL STUDY RATIONALE, METHODOLOGY, INNOVATION AND IMPLICATIONS

Posted in News | Comments Off on A MULTICENTER RANDOMIZED CONTROLLED TRIAL OF SURVEILLANCE VERSUS ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: THE SURVENT TRIAL STUDY RATIONALE, METHODOLOGY, INNOVATION AND IMPLICATIONS